BRAF and thyroid cancer: Notably, thyroid cancers have the highest frequency of recurrent kinase fusions (63/498, 13%), and all fusion events including ALK, BRAF, MET, NTRK1, NTRK2, RAF1 and RET are mutually exclusive in this cancer type (Fig. 4).